Skip Navigation Links.
American Journal of Sports Science and Medicine. 2019, 7(2), 51-60
DOI: 10.12691/AJSSM-7-2-5
Original Research

The Comparison of Stationary Bike Training and Standard Treadmill Therapy in Overweight and Obese Patients Age 40-55 with Peripheral Artery Disease (PAD) in Fontaine’s Stage IIa on High Dose Supplementation Support of Alpha-Lipoic Acid (ALA)

Sid Solakovic1, Emir Solakovic2, Ratko Pavlovic3, , Amina Ahmovic3, Mensur Vrcic3 and Nedim Covic3

1Clinic for Cardiovascular Surgery Clinical Center of University of Sarajevo, Department for Vascular and Endovascular Surgery, BIH

2Faculty of Sport and Physical Education, University of Sarajevo, BIH

35Faculty of Sport and Physical Education, University of Sarajevo, BIH

Pub. Date: June 28, 2019
Full Text PDF

Cite this paper

Sid Solakovic, Emir Solakovic, Ratko Pavlovic, Amina Ahmovic, Mensur Vrcic and Nedim Covic. The Comparison of Stationary Bike Training and Standard Treadmill Therapy in Overweight and Obese Patients Age 40-55 with Peripheral Artery Disease (PAD) in Fontaine’s Stage IIa on High Dose Supplementation Support of Alpha-Lipoic Acid (ALA). American Journal of Sports Science and Medicine. 2019; 7(2):51-60. doi: 10.12691/AJSSM-7-2-5

Abstract

Aim: The aim of the applicative study was to estimate the increasing capability of claudications distance in Fontaine's stage IIa patients of Peripheral artery disease (PAD) with Body Mass Index (BMI) 25-34,9 kg/m2 and Ankle Brachial Index (ABI) 0,8-0,9 by comparing Stationary Bike on High Dose of Alpha-Lipoic Acid (ALA) versus Treadmill wallking program on standard Dose of Alpha-Lipoic Acid (ALA) in Exercise Therapy with life style modification. Patients and methods: This study was conducted from beginning of May, 2017 till end of May, 2018 at the Clinic for Cardiovascular Surgery Clinical Center and Department for vascular and endovascular surgery, University of Sarajevo, Special Hospital dr. Solakovic, Sarajevo and Faculty of Sport and Physical Education, University of Sarajevo. In the study included 60 male patients, age 40-55 with Peripheral Artery Disease (Ankle Brachial Index/ABI) 0,8-0,9, and Body Mass Index (BMI) 25 to 34,9 kg/m2 (30 non surgical traetment patients on standard Treadmill wallking program (control group) and research group consisting of 30 non surgical treatment patients on Stationary Bike), in stadium IIa of peripheral artery disease, with manifestation of mild claudication simptoms. For the testing of statistical significance of differences between the examinated groups parametric tests were used. The difference at a level of (p<0,05) was statistically significant. Results: Analysis shows the no statistically significantdifference between on claudication distance inStationary Bike grupsand impellers standard Treadmill wallking group (p>0,05). Conclusion: Stationary Bike Interval Training can be alternative vascular Therapy and has his on benefits but he can notentirely replace Treadmill Therapy in Patients with Peripheral Artery Disease with BMI 25-34.9kg/m2. Treadmill Rehabilitation Therapy still remain generally main strategy of the therapeutic effect on enhancement of claudication distance (Fontaine's stage II) of peripheral artery disease.

Keywords

stationary bike, treadmill therapy, Peripheral Aartery Disease (PAD), claudication distance, BMI 25-34.9kg/m2

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Huang Y, Xu M, Xie L et al. ''Obesity and peripheral arterial disease: A Mendelian Randomization analysis'' Atherosclerosis. 2016 ;247:218-24.
 
[2]  Shahar, E. ''The association of body mass index with health outcomes: causal, inconsistent, or confounded?''. Am. J. Epidemiol. 2009; 170: 957–958.
 
[3]  Ix, J.H., Biggs, M.L., Kizer, J.R. et al. ''Association of body mass index with peripheral arterial disease in older adults: the Cardiovascular Health Study''. Am. J. Epidemiol. 2011; 174: 1036-1043.
 
[4]  Berg AH, Scherer PE ''Adipose tissue, inflammation, and cardiovascular disease''. Circ Res (2005) 96: 939-94.
 
[5]  Tison, G.H., Ndumele, C.E., Gerstenblith, G. et al. ''Usefulness of baseline obesity to predict development of a high ankle brachial index (from the Multi-Ethnic Study of Atherosclerosis)''. Am. J. Cardiol. 2011; 107: 1386-1391.
 
[6]  Fall, T., Hagg, S., Magi, R. et al. ''The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis''. PLOS Med. 2013;10:e1001474.
 
[7]  Cronin, O., Morris, D.R., Walker, P.J. et al. ''The association of obesity with cardiovascular events in patients with peripheral artery disease''. Atherosclerosis. 2013;228:316-323.
 
[8]  Gardner AW, Poehlman ET. ''Exercise rehabilitation programs for the treatment of claudication pain: a meta-analysis''. JAMA 1995; 274: 975-80.
 
[9]  Dahllof A, Holm J, Schersten T, Sivertsson R.Scand at al. ''Peripheral arterial insufficiency. Effect of physical training on walking distance'' J Rehabilitation Med, 1976
 
[10]  Regensteiner JG, Hargarten ME, Rutherford RB, Hiatt WR. ''Functional benefits of peripheral vascular bypass surgery for patients with intermittent claudication'' Vascular Surg, 1Eur J Vasc Surg 1988 (2): 151-154.
 
[11]  Galea, M.N., Bray, S.R., & Ginis, K.A. ''Barriers and facilitators for walking in individuals with intermittent claudication'' Journal of Aging and Physical Activity, 2008; 16 (1), 69-83.
 
[12]  Lavie CJ, Milani RV, Ventura HO. ''Obesity, heart disease, and favorable prognosis—truth or paradox?'' Am J Med. 2007; 120: 825-826.
 
[13]  US Department of Health and Human Services. The Surgeon General’s Call to Action to Prevent and Decrease Overweight and Obesity. Rockville, MD: US Department of Health and Human Services, Public Health Service, Office of the Surgeon General; 2001.
 
[14]  Lavie CJ, Morshedi-Meibodi A, Milani RV. ''Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients''. J Cardiometab. Syndr. 2008; 3: 136–140.
 
[15]  Hankey, G.J., Norman, P.E., & Eikelboom, J.W.''Medical treatment of peripheral arterial disease''. The Journal of the American Medical Association, 2006; 295(5), 547-553.
 
[16]  Lane, R., Ellis, B., Watson, L., & Leng, G.C. Exercise for intermittent claudication. Cochrane Database of Systematic Reviews, 2014; 18(7), 990-1002.
 
[17]  Solakovic,S., Vrcic,M., Pavlovic, R. ''Benefits Of Physical Activity On Diabetic And Nondiabetic Patients In Fontaine’s Stage IIa Of Peripheral Artery Disease In Bosnia And Herzegovina''. Journal of Physical Education Research, 2016; 3, (2): 23-33.
 
[18]  Maly, R., Chovanec, V. ''Peripheral arterial disease and diabetes''. V nitr. Lek. 2010;56:341-346.
 
[19]  Meru AV, Mittra S, Thyagarajan B, Chugh A. ''Intermittent claudication: an overview''. Atherosclerosis. 2006; 187: 221-37.
 
[20]  Semenza, G.L. ''Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling''. Journal of Cell Biochemistry, 2007; 102(4), 840- 847.
 
[21]  Tsai, J.C., Chan, P., Wang, C.H., Jeng, C., Hsieh, M.H., Kao, P.F., Chen, Y.J., & Liu, J.C. ''The effects of exercise training on walking function and perception of health status in elderly patients with peripheral arterial occlusive disease''. Journal of International Medicine, 2002; 252(5), 448-455.
 
[22]  McDermott MM. ''Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia''. Circ Res. (2015);116:1 540-50.
 
[23]  McDermott, M.M., Liu, K., Greenland, P., Guralnik, J.M., Criqui, M.H., Chan, C., Pearce, W.H., Schneider, J.R., Ferrucci, L., Celic, L., Taylor, L.M., Vonesh, E., Martin, G.J., Clark, E. ''Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms''. JAMA. 2004;292:453-461.
 
[24]  Criqui, M.H., Langer, R.D., Fronek, A., Feigelson, H.S., Klauber, M.R., McCann, T.J., Browner, D. ''Mortality over a period of 10 years in patients with peripheral arterial diseas''e. N. Engl. J. Med. 1992; 326: 381-386.
 
[25]  McDermott, M.M., Greenland, P., Liu, K., Guralnik, J.M., Celic, L., Criqui, M.H., Chan, C., Martin, G.J., Schneider, J., Pearce, W.H., Taylor, L.M., Clark, E. ''The ankle brachial index is associated with leg function and physical activity: the wallking and leg circulation study''. Ann. Intern Med. 2002; 136: 873-883.
 
[26]  Clinical practice guidelines of peripheral artery disease for people with intermittent claudication developed by the Vascular Disease Foundation (VDF) and the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR).
 
[27]  Schnohr P1, Marott JL, Jensen JS et al. ''Intensity versus duration of cycling, impact on all-cause and coronary heart disease mortality: the Copenhagen City Heart Study''. Eur J Prev Cardiol. 2012 Feb;19(1):73-80.
 
[28]  Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A. ''Walking compared with vigorous exercise for the prevention of cardiovascular events in women''. N Engl J Med 2002; 347: 716-725.
 
[29]  Matthews CE, Jurj AL, Shu XO, Li HL, Yang G, Gao YT., ''Influence of exercise, walking, cycling, and overall nonexercise physical activity on mortality in Chinese women''. Am J Epidemiol 2007; 165: 1343-1350.
 
[30]  Schnohr P. ''Physical activity in leisure time: impact on mortality. Risks and benefits''. Thesis. Dan Med Bull 2009; 56: 40-71.
 
[31]  Rauramaa R, Salonen JT, Seppänen K, Salonen R, Venäläinen JM, Ihanainen M. ''Inhibition of platelet aggregation by moderate-intensity physical exercise: a randomised clinical trial in overweight men''. Circulation 1986; 74: 939-944.
 
[32]  Gillespie GN, Porteous AJ et al. ''Obesity and knee arthroplasty'' Knee. 2007 Mar; 14(2): 81-6.
 
[33]  Tamura LS, Cazzo E, Chaim EA, Piedade SR. Et al. ''Influence of morbid obesity on physical capacity, knee-related symptoms and overall quality of life: A cross-sectional study'' Rev Assoc Med Bras (1992). 2017 Feb;63(2): 142-147.
 
[34]  Ackerman IN, Kemp JL, Crossley KM, Culvenor AG, Hinman RS. ''Hip and Knee Osteoarthritis Affects Younger People, Too''. J Orthop Sports Phys Ther. 2017 Feb; 47(2): 67-79.
 
[35]  Reed A.B,Conte M.S,Donadlson et al. ''The impact of patient age and aortic size on the results of aortobifemoral bypass grafting'' J.Vasc Surg 2003; 37 1219-25.
 
[36]  Olsen P.S.,Gustavsen J.,Rasmussen L et al. ''Long term results after arterial surgery for arteriosclerosis of lower limb in young adults'' Eur J Vasc Surgery,1988; 2: 15-8.
 
[37]  Baum, B. ''Lower extremity muscle activities during cycling are influenced by load and frequency.'' Journal of Electromyography and Kinesiology:2003; (13), 181-190.
 
[38]  Gardner, A.W., Forrester, L.,et al. ''Altered gait profile in subjects with peripheral arterial disease'' Vasc Med. 2001; 6: 31-34.
 
[39]  Ibrahimpasic et al. ''Alpha lipoic acid and glycaemic control in diabetic neuropathies at type 2 diabetes treatment.'' Med Arch. 2013; 67(1): 7-9.
 
[40]  Eun Hee Koh et al. ''Effects of Alpha-Lipoic Acid on Body Weight in Obese Subjects.'' The American Journal of Medicine, 2011; 124 (1) 85. e1-85.e8.
 
[41]  Haak E. at al. ''Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy'' Exp Clin Endocrinol Diabetes. 2000; 108(3): 168-74.
 
[42]  Vincent HK et al. ''Effects of alpha-lipoic acid supplementation in peripheral arterial disease: a pilot study.'' J Altern Complement Med. 2007 Jun; 13(5): 577-84.
 
[43]  Sanderson, B. and al. ''Short-term effects of cycle and treadmill training on exercise tolerance in peripheral arterial diseas'' J Vasc Surg 2006; 44: 119-27.
 
[44]  Heinisch BB, Francesconi M, Mittermayer F, et al. ''Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial''. Eur J Clin Invest. Feb 2010; 40 (2): 148-154.
 
[45]  Xiang GD, Sun HL, Zhao LS, Hou J, Yue L, Xu L. ''The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance''. Clin Endocrinol (Oxf). May 2008; 68 (5): 716-723.
 
[46]  De Oliveira AM, Rondo PH, Luzia LA, D'Abronzo FH, Illison VK. ''The effects of lipoic acid and alpha-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial''. Diabetes Res Clin Pract. May 2011; 92(2): 253-26.
 
[47]  Zhang Y, Han P, Wu N, et al. ''Amelioration of lipid abnormalities by alpha-lipoic acid through antioxidative and anti-inflammatory effects.'' Obesity (Silver Spring). Aug 2011; 19(8): 1647-1653.
 
[48]  Deck C et al. ''Effects of modest doses of omega-3 fatty acids on lipids and lipoproteins in hypertriglyceridemic subjects. A randomized controlled trial''. Arch Intern Med. 1989 149; (8): 1857-62.
 
[49]  Connor WE et al. ''N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients.'' Ann N Y Acad Sci. 1993; (14), 683: 16-34.